{"meta":{"id":"https:\/\/api.iclient.ifeng.com\/ipadtestdoc?aid=ucms_7xXdDrKgjhF","type":"doc","o":"1","documentId":"ucms_7xXdDrKgjhF"},"body":{"newStatus":"1","documentId":"ucms_7xXdDrKgjhF","staticId":"ucms_7xXdDrKgjhF","title":"上海市经信委总工程师赴药明康德调研","shareTitle":"上海市经信委总工程师赴药明康德调研","thumbnail_doc":"","thumbnail":"","source":"证券时报","author":"","editorcode":"weMedia","editTime":"2020-06-23 17:52:20","updateTime":"2020\/06\/23 17:52:20","wapurl":"http:\/\/\/\/finance.ifeng.com\/c\/7xXdDrKgjhF","introduction":"","wwwurl":"http:\/\/\/\/finance.ifeng.com\/c\/7xXdDrKgjhF","commentsUrl":"ucms_7xXdDrKgjhF","commentCount":0,"text":"
证券时报e公司讯,据上海市经信委消息,6月22日下午,上海市经信委总工程师刘平赴药明康德(603259)和中国(上海)自贸区管委会调研。刘平指出,药明康德下一步应考虑战略性布局,制定全面战略规划;发挥自身平台优势,打造外高桥生物医药生态圈,推动上海市生物医药产业高质量快速发展;利用人工智能等新技术赋能新药研发,大幅提升新药研发效率;加强人才和团队建设,完善激励机制,调动发挥人才的积极性、创新力。<\/p>","img":[],"summary":"证券时报e公司讯,据上海市经信委消息,6月22日下午,上海市经信委总工程师刘平赴药明康德(603259)和中国(上海)自贸区管委会调研。刘平指出,药明康德下一步","sharesummary":"证券时报e公司讯,据上海市经信委消息,6月22日下午,上海市经信委总工程师刘平赴药明康德(603259)和中国(上海)自贸区管委会调研。刘平指出,药明康德下一步","commentType":"0","wemediaEAccountId":"706","showclient":"0","shareurl":"https:\/\/ishare.ifeng.com\/c\/s\/v002SrQ30WaMB7Jz9CrL-_24BKBCVZBj7j7KhOcrw4srdwfY__","praise":"0","like_num":"0"}}